Key takeaways
Admelog (insulin lispro) and NovoLog (insulin aspart) are both rapid-acting insulins used to improve blood sugar control in people living with diabetes. Admelog contains insulin lispro, while NovoLog contains insulin aspart. Both start working in about 15 minutes, are typically injected just before meals. For most people, they provide similar blood sugar control, so the choice often comes down to factors such as insurance coverage, cost, insulin delivery device compatibility, and individual response.
